Screener
AngioDynamics ANGO EBITDA margin
EBITDA margin at other companies
Other financials
Where this comes from
Calculated from AngioDynamics’s reported figures.
Based on trailing twelve months.
The source filing: AngioDynamics’s 10-K, filed July 14, 2026. Open the filing →
- Filed
- Jul 14, 2026, 3:42 PM EDT
- Fiscal year
- FY2026
- Accession
- 0001628280-26-048138
FAQ
- What is AngioDynamics's EBITDA margin?
- AngioDynamics (ANGO) reported EBITDA margin of -5.3% in Q1 2026.
- How has AngioDynamics's EBITDA margin changed year-over-year?
- AngioDynamics's EBITDA margin decreased by 9.5% year-over-year, from -4.8% to -5.3%.
- What is the long-term trend for AngioDynamics's EBITDA margin?
- Over 5 years (2021 to 2026), AngioDynamics's EBITDA margin has grown at a 10.5% compound annual growth rate (CAGR), from -3.2% to -5.3%.
- What does EBITDA margin mean?
- EBITDA (earnings before interest, taxes, depreciation, and amortization) as a percentage of revenue, trailing twelve months. A proxy for cash operating profitability that strips out capital-structure and non-cash charges.
Ask your AI about AngioDynamics's ebitda margin.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude